Quinethazone
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 318601

CAS#: 73-49-4

Description: Quinethazone is a thiazide diuretic used to treat hypertension. Common side effects include dizziness, dry mouth, nausea, and low potassium levels.


Price and Availability

Size
Price

5mg
USD 950
Size
Price

Size
Price

Quinethazone,, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 318601
Name: Quinethazone
CAS#: 73-49-4
Chemical Formula: C10H12ClN3O3S
Exact Mass: 289.02879
Molecular Weight: 289.74
Elemental Analysis: C, 41.45; H, 4.17; Cl, 12.24; N, 14.50; O, 16.57; S, 11.07


Synonym: Quinethazone; Chinethazonum; Quinethazon; Quinethazonum; Aquamox; Hydromox; quinethazone, (+)-isomer; quinethazone, (+-)-isomer; quinethazone, (-)-isomer;

IUPAC/Chemical Name: 7-chloro-2-ethyl-4-oxo-2,3-dihydro-1H-quinazoline-6-sulfonamide

InChi Key: AGMMTXLNIQSRCG-UHFFFAOYSA-N

InChi Code: InChI=1S/C10H12ClN3O3S/c1-2-9-13-7-4-6(11)8(18(12,16)17)3-5(7)10(15)14-9/h3-4,9,13H,2H2,1H3,(H,14,15)(H2,12,16,17)

SMILES Code: CCC1NC2=CC(=C(C=C2C(=O)N1)S(=O)(=O)N)Cl


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO, not in water

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Harmonized System Code:
293490


References

1: Olesen KH, Sigurd B. The supra-additive natriuretic effect addition of
quinethazone or bendroflumethiazide during long-term treatment with furosemide
and spironolactone. Permutation trial tests in patients with congestive heart
failure. Acta Med Scand. 1971 Sep;190(3):233-40. PubMed PMID: 4941227.

2: Olesen KH, Dupont B, Flensted-Jensen E. The combined diuretic action of
quinethazone and furosemide in congestive heart failure. A permutation trial
test. Acta Med Scand. 1970 Jan-Feb;187(1-2):33-40. PubMed PMID: 4912468.

3: Trifunović S, Stamenković Z. [The use of quinethazone in the treatment of
cardiac edema]. Med Glas. 1966 Jul;20(7):246-8. Serbian. PubMed PMID: 5986856.

4: Merker W, Bauer HR. [Quinethazone and acetazolamide in edematous diseases].
Med Klin. 1966 May 13;61(19):764-8. German. PubMed PMID: 5988324.

5: Angelopoulos B, Vlassopoulos C, Kalos A. Experimental investigation and
observations on the diuretic action of quinethazone. Med Pharmacol Exp Int J Exp
Med. 1966;14(6):528-36. PubMed PMID: 6012607.

6: Naik BK, Rao PS, Saboo RM, Parlay K. Clinical trial of Quinethazone--Reserpine
(diuretic cum antihypertensive--drug). J Assoc Physicians India. 1965
Aug;13(8):637-41. PubMed PMID: 5825030.

7: Baur M. [Pharmacologic-clinical tests of new diuretics. 1. Quinethazone].
Arzneimittelforschung. 1965 Jul;15(7):806-12. German. PubMed PMID: 5324710.

8: Diamond S, Feldman E. [Treatment of essential hypertension with quinethazone
and reserpine]. Hospital (Rio J). 1965 Jul;68(1):83-8. Portuguese. PubMed PMID:
5322319.

9: Kozma JJ. [Use of quinethazone combined with reserpine in hypertension]. Folha
Med. 1965 Jun;50(6):413-7. Portuguese. PubMed PMID: 5850507.

10: Rognoni M, Guevara F, Brown A. [Quinethazone (Aquamox Lederle)]. Arch Med
Panamenos. 1965 Apr;14(1):17-22. Spanish. PubMed PMID: 5839433.

11: KOZMA JJ. CLINICAL EVALUATION OF QUINETHAZONE-RESERPINE COMBINATION IN
HYPERTENSION. Curr Ther Res Clin Exp. 1964 Nov;6:664-9. PubMed PMID: 14240756.

12: RIOSMOZO M. [TREATMENT OF ARTERIAL HYPERTENSION WITH QUINETHAZONE AND
QUINETHAZONE-RESERPINE]. Hisp Med. 1964 Aug;21:465-83. Spanish. PubMed PMID:
14202221.

13: KLEINSCHMIDT A, LUDWIG H. [INCREASED NATRIURESIS BY MEANS OF A DIURETIC
COMBINATION (QUINETHAZONE-ACETAZOLAMIDE)]. Med Klin. 1964 Jun 26;59:1063-8.
German. PubMed PMID: 14243296.

14: HUTCHEON DE, LEONARD GB, LONIEWSKI AE. BIOASSAY OF DIURETICS IN CONGESTIVE
HEART FAILURE. A COMPARISON OF QUINETHAZONE WITH HYDROCHLOROTHIAZIDE. J New
Drugs. 1964 May-Jun;4(3):148-53. PubMed PMID: 14185005.

15: HUTCHISON JC, ROEDIGER PM, WERBLIN M. CHOLESTATIC JAUNDICE FOLLOWING
ADMINISTRATION OF QUINETHAZONE. Curr Ther Res Clin Exp. 1964 Mar;6:199-201.
PubMed PMID: 14131421.

16: DIAMOND S, FELDMAN E. TREATMENT OF ESSENTIAL HYPERTENSION WITH QUINETHAZONE
PLUS RESERPINE. Curr Ther Res Clin Exp. 1964 Jan;6:62-6. PubMed PMID: 14105061.

17: FREED SC. MECHANISM OF ANTI-HYPERTENSIVE ACTION OF QUINETHAZONE. Proc Soc Exp
Biol Med. 1963 Nov;114:421-2. PubMed PMID: 14101206.

18: HALLESY DW, BENITZ KF. [TOXICITY TESTS OF QUINETHAZONE].
Arzneimittelforschung. 1963 Aug;13:665-73. German. PubMed PMID: 14085919.

19: SHIOJI T, FURUYAMA T, ABE S, SUZUKI C, MAKABE K, RIKIMARU S. [STUDIES ON
DIURETIC AND ANTIHYPERTENSIVE EFFECTS OF QUINETHAZONE]. Naika Hokan. 1963
Aug;10:397-405. Japanese. PubMed PMID: 14057126.

20: DATEY KK, PANDYA VN. QUINETHAZONE AS A DIURETIC AGENT. J Postgrad Med. 1963
Jul;9:99-105. PubMed PMID: 14066683.